Larimar Therapeutics, Inc. (LRMR) Financials

LRMR Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 95.9 million 14.2 million
2023-09-30 104.0 million 11.2 million
2023-06-30 111.7 million 11.8 million
2023-03-31 118.9 million 12.7 million

LRMR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -9.5 million 1.9 million
2023-09-30 -9.2 million 1.8 million
2023-06-30 -7.4 million 2.0 million
2023-03-31 -7.6 million 1.8 million

LRMR Net Income

No data available :(

LRMR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 86.8 million - 5.5 million
2023-09-30 95.6 million - 5.4 million
2023-06-30 104.2 million - 5.1 million
2023-03-31 111.5 million - 5.2 million

LRMR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 43.9 million
2023-09-30 43.9 million
2023-06-30 43.9 million
2023-03-31 43.9 million

LRMR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 164000 10.6 million 3.5 million -
2023-09-30 - 6.6 million 3.8 million -
2023-06-30 - 5.9 million 3.7 million -
2023-03-31 - 4.6 million 3.1 million -

LRMR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 81000
2023-09-30 - 69000
2023-06-30 - 49000
2023-03-31 - 54000

LRMR

Price: $6.44

52 week price:
2.18
13.68

Earnings Per Share: -0.84 USD

P/E Ratio: -10.25

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 194

Market Capitalization: 474.7 million

Links: